Security Type

Security Class Title

Fee Calculation

or Carry

Forward Rule

Amount

Registered(1)

Proposed Maximum
Offering Price Per Unit

Maximum

Aggregate Offering

Price

Fee Rate

Amount of Registration

Fee

Fees to Be Paid

Equity

Ordinary Shares, par value NIS 0.07 per share (“Ordinary Shares”)

Other⁽²⁾

1,168,866 ⁽³⁾

$17.77⁽²⁾

$20,770,748.82

$0.0001531

$ 3,180.01

Equity

Ordinary Shares

Other⁽⁴⁾

248,100⁽⁵⁾

$18.54⁽⁴⁾

$4,599,774

$0.0001531

$704.23

Equity

Ordinary Shares

Other⁽²⁾

21,950⁽⁶⁾

$17.77⁽²⁾

$390,051.50

$0.0001531

$59.72

Total Offering Amounts

1,439,016

$ 25,760,574.32

$ 3,943.96

Total Fees Previously Paid

--

 Total Fee Offsets

--

 Net Fee Due

$3,943.96

(1)

In accordance with Rule 416(a) under the Securities Act of 1933, as amended (“Securities Act”), this registration statement shall be deemed to cover such indeterminate number of Ordinary Shares as may be offered or issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions pursuant to the terms of the MediWound Ltd. 2024 Share Incentive Plan, as amended (the “2024 Plan”).

(2)

Estimated in accordance with Rules 457(c) and 457(h) solely for the purpose of calculating the registration fee on the basis of $17.77 per share, which represents the average of the high ($18.2871) and low ($17.235) prices of the ordinary shares as reported on the Nasdaq Global Market on March 12, 2025.

(3)

Represents ordinary shares available for issuance pursuant to potential future grants under the 2024 Plan, including ordinary shares that may be rolled over to the 2024 Plan from the MediWound Ltd. 2014 Equity Incentive Plan (the “2014 Plan”), upon expiration, cancelation, termination, forfeiture, repurchase, or settlement in cash in lieu of issuance of shares, of awards under the 2014 Plan.

(4)

Calculated in accordance with Rule 457(h)(1) promulgated under the Securities Act, based on the exercise price of outstanding options that have been granted under the 2024 Plan.

(5)

Consists of ordinary shares issuable upon exercise of options that are outstanding under the 2024 Plan, which options are exercisable at the exercise price shown in this row in the column “Proposed Maximum Offering Price Per Unit”

(6)

Consists of ordinary shares issuable upon vesting and settlement of Restricted Shares Units (RSUs) that are outstanding under the 2024 Plan.